Intuitive Surgical is the 800-pound gorilla in the robotic surgery realm.
It has more than 11,000 systems installed worldwide.
It's growing in part by obtaining approval to perform more kinds of procedures.
The fact that, per Fidelity, a 65-year-old person retiring in 2025 could expect to spend $172,500, on average, on medical and healthcare expenses throughout their retirement makes clear what most of us know: Healthcare is costly. That's not great news for us as patients, but for investors, it suggests that there's a lot of money to be made in healthcare.
One of the most successful companies in the healthcare realm is Intuitive Surgical (NASDAQ: ISRG), the giant in robotic surgeries. It's also a company embracing artificial intelligence (AI). I'm a shareholder, and I plan to hold on to my shares for a very long time. Here's why.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Image source: Getty Images.
The Intuitive Surgical website announces that "we believe minimally invasive care is life-enhancing care." And it shares some impressive numbers:
Its success with the da Vinci system has been remarkable, and the company now has another system -- the Ion, for robotic bronchoscopies and lung biopsies.
The icing on the cake with this company is that only about a quarter of its revenue comes from selling its extremely expensive systems. The rest is from servicing and supplies -- and that's dependable, recurring revenue.
Intuitive is still posting impressive numbers. In its solid fourth quarter, it reported worldwide procedures up 18% year over year and 532 da Vinci systems installed (up from 493 a year prior). Revenue was up 19% year over year. Check out the stock's performance, too:
|
Time Period |
Average Annual Return |
|---|---|
|
Past 1 year |
(16.88%) |
|
Past 3 years |
26.39% |
|
Past 5 years |
13.52% |
|
Past 10 years |
23.86% |
|
Past 15 years |
18.78% |
Source: Data from Morningstar.com as of Feb. 10, 2026.
The company is growing not only by adding machines, but also by expanding their use. The da Vinci 5 system, for example, was recently approved for certain cardiac procedures.
Intuitive is sitting on a wealth of data from more than 10 million procedures that have been performed with its systems, and it's using AI to draw insights from that data that can improve the system even more. With respect to the Ion system, Intuitive notes that:
Ion's latest AI-powered enhanced navigation builds on its existing strengths to address a key challenge in lung biopsy known as CT-to-body divergence -- when a lung nodule is in a different location ... Ion will now use AI to help correct this in real time.
If you're itching to invest in Intuitive Surgical right now, perhaps hold off because this growth stock is not exactly cheap, though it is priced lower right now than it was last year. Opinions will vary, but at best, it's fairly valued. So you might wait for a pullback, invest in the company incrementally, or just jump in as long as you plan to hang on for many years through downturns and upturns.
Before you buy stock in Intuitive Surgical, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Intuitive Surgical wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $414,554!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,120,663!*
Now, it’s worth noting Stock Advisor’s total average return is 884% — a market-crushing outperformance compared to 193% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of February 16, 2026.
Selena Maranjian has positions in Intuitive Surgical. The Motley Fool has positions in and recommends Intuitive Surgical. The Motley Fool recommends the following options: long January 2028 $520 calls on Intuitive Surgical and short January 2028 $530 calls on Intuitive Surgical. The Motley Fool has a disclosure policy.